
Market research reports on: Pharmaceutical manufacture, cancer, oncology, prevention and treatment, therapeutics, vaccines, clinical studies, drug delivery, immunology, immunotherapy and others.
Let's ConnectNeurostimulation: Technologies and Global Markets
The global neurostimulation devices market should reach $11.7 billion by 2028 from $8.2 billion in 2023 at a compound annual growth rate (CAGR) of 7.4% for the forecast period of 2023 to 2028. Whereas the market was $7.7 billion in 2022 (base year).
Global Markets for Treatments for Syndromes of Progressive Ataxia...
The global progressive ataxia and weakness disorders market reached $32.0 billion in 2022, should reach $35.1 billion by 2023 and $57.2 billion by 2028 with a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2023-2028.
Global Acute Myeloid Leukemia (AML) Treatment Market: Forecast a...
The global acute myeloid leukemia (AML) treatments market should reach $6.1 billion by 2028 from $3.8 billion in 2023 at a compound annual growth rate (CAGR) of 10.0% for the forecast period of 2023 to 2028.
Minimal Residual Disease Testing: Global Markets and Technologies
The global market for minimal residual disease testing is estimated to increase from $2.2 billion in 2023 to reach $4.3 billion by 2028, at a compound annual growth rate (CAGR) of 14.3% from 2023 through 2028.
Cannabis: The Medicinal Use
This report provides its readers with the history, components, and types of Cannabis. It gives a brief picture of how cannabis is affecting different parts of the body and its use in different medical conditions. Having strong components makes it useful for medical purposes, but not everyone can access it, so having alternative plants with similar strains mentioned in the report will help the readers explore more alternatives. However, strict rules on the consumption and sale of cannabis are illegal so this report covers the regulations that have to be followed in the top 10 countries for the buying and selling of cannabis for medical purposes.
Veterinary Vaccines: Global Markets
The global veterinary vaccines market reached $9.1 billion in 2022, should reach $9.6 billion by 2023 and $14.2 billion by 2028 with a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2023-2028.
Markets for Advanced Wound Management Technologies
The global advanced wound management products market reached $10.7 billion in 2022 and should reach $15.3 billion by 2028, with a compound annual growth rate (CAGR) of 6.2% during the forecast period of 2023-2028.
Epigenetic Therapeutics: Global Markets
The global market for epigenetic therapeutics is estimated to increase from $6.8 billion in 2023 to reach $9.8 billion by 2028, at a compound annual growth rate (CAGR) of 7.7% from 2023 through 2028.
Regenerative Medicines: Bone and Joint Applications
The global market for regenerative medicine in bone and joint applications reached $9.6 billion in 2022. The market is estimated to increase from $10.7 billion in 2023 to $18.9 billion by 2028, at a compound annual growth rate (CAGR) of 12.1% from 2023 through 2028.
Antibiotics: Technologies and Global Markets
The global antibiotics market reached $40.4 billion in 2022 and should reach $49.6 billion by 2027, with a compound annual growth rate (CAGR) of 4.2% during the forecast period of 2022-2027.
Global Markets and Technologies for Pandemic Control
The global infectious diseases market reached $238.5 billion in 2022 and should reach $300.8 billion by 2027, with a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2022-2027.
Psychedelic Drugs: Global Market Outlook
The report provides an overview of the global psychedelic drugs market. This report includes sales forecasts and trends in the market for psychedelic drugs through 2027. It discusses leading companies in the market, product segments, supporting technologies, market dynamics, competitive intelligence and regional trends.
Transdermal Patches: Global Markets
The global market for transdermal patches is estimated to increase from $6.7 billion in 2022 to reach $8.8 billion by 2027, at a compound annual growth rate (CAGR) of 5.6% from 2022 through 2027.
Best Selling Pharmaceutical Drugs in 2021
This report discusses the pharmaceutical industry and its competitive landscape and sales of the top 50 bestselling drugs in 2021, in terms of major player market ranking and top 50 pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence and regional trends have been well-researched and analyzed in this report.
Drugs of Abuse Testing: Technologies and Global Markets
The global market for drugs of abuse (DOA) testing is estimated to increase from $5.2 billion in 2022 to reach $8.1 billion by 2027, at a compound annual growth rate (CAGR) of 9.3% from 2022 through 2027.
Nasal Vaccines: Global Markets and Pipeline Analysis
The global market for nasal vaccines is estimated to increase from $383.8 million in 2022 to reach $568.1 million by 2027, at a compound annual growth rate (CAGR) of 8.2% from 2022 through 2027.
Helicobacter pylori Testing: Global Market Outlook
This report provides a brief general outlook of the global market for Helicobacter pylori testing. The report discusses the current and future strategies of vendors in the H. pylori testing market, which includes various invasive and non-invasive tests used to detect H. pylori. The revenues are broken down by region and have been estimated for the five-year period from 2022 through 2027. The report also present details with respect to Helicobacter pylori testing kits.
Bronchitis Treatments: Global Markets
The global market for bronchitis treatments is estimated to grow from $5.8 billion in 2022 to $6.9 billion in 2027, with a compound annual growth rate (CAGR) of 3.5% for the period of 2022-2027.
Regulatory Intelligence Report for Pharmaceuticals in the U.S.
This report presents an understanding of the regulations and requirements of companies in the U.S., as well as foreign companies or establishments planning to manufacture, distribute or market their pharmaceuticals in the U.S. This report provides a brief about the related regulations for registration of the establishments and pharmaceuticals.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2021
This report discusses exhaustive coverage of the pharmaceutical industry and its competitive landscape in terms of major player market ranking and top pharmaceutical drugs. Company profiles of the top fifty pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence and regional trends are well researched and analyzed in this report. The study include tracking alliances, joint ventures, mergers and acquisitions, new product development and R&D in the global pharmaceutical drugs market and the factors that will affect the industry in the coming years.
Pediatric Vaccines: Global Markets
The global pediatric vaccines market should reach $34.5 billion by 2022 and more than $50.2 billion by 2027, with a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2022-2027.
Head and Neck Cancer Therapeutics: Global Markets
The global market for head and neck cancer therapeutics is estimated to increase from $1.7 billion in 2022 to $2.6 billion by 2027, at a compound annual growth rate (CAGR) of 8.5% from 2022 through 2027.
Global Markets and Technologies for Advanced Drug Delivery System...
The global market for advanced drug delivery systems is estimated to increase from $275.0 billion in 2022 to reach $376.8 billion by 2027, at a compound annual growth rate (CAGR) of 6.5% during the forecast period (2022-2027).
Laboratory Automation Systems and Processes: Global Markets and T...
The global market for laboratory automation systems and processes is valued at $11.9 billion in 2021 and is estimated to grow from $12.7 billion in 2022 to $18.7 billion in 2027 with a compound annual growth rate (CAGR) of 7.9% for the period of 2022-2027.
Laboratory Animal Models, 3D Cultures and Organoids: Global Marke...
The global market for organoids is estimated to increase from $1.4 billion in 2022 to reach $3.7 billion by 2027 with a compound annual growth rate (CAGR) of 22.2% from 2022 through 2027.
Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets
This report includes:
- Overview and an up-to-date analysis of the global markets for antithrombotic/anticoagulant drugs for the treatments of thrombotic (cardiovascular) disease
- Analyses of the global market trends, with historical market revenue data (sales figures) for 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Examination of the market potential for antithrombotic/anticoagulant drugs, and quantification of the global market for these drugs and its market segments and sub-segments over the next five years
- Estimate of the actual market size and revenue forecast for the market, and corresponding market share analysis based on product type, application and region
- In-depth information (facts and figures) pertaining to the market drivers, challenges, opportunities and prospects, as well as the technologies, regulatory scenarios and impact of COVID-19
- Analysis of market growth opportunities with a holistic review of Porter’s Five Forces and PESTLE analyses, taking into consideration the prevailing micro- and macroeconomic factors in the market
- A look at the major vendors in the global market for antithrombotic/anticoagulant drugs, and analysis of the healthcare industry structure, including market shares and recent mergers and acquisitions (M&A) activity
- Review of key patent grants and a look at breakthrough innovations, novel products, upcoming trends and technologies, and emerging applications for cardiovascular treatments
- Insight into the importance of ESG in the worldwide market, with a look at consumer attitudes, risks and opportunities assessment, and ESG practices followed by manufacturers and service providers
- Identification of the major stakeholders, and analysis of the competitive landscape based on recent developments, key financials and segmental revenues, and operational integration
- Profiles of the leading market players
Melanoma Therapeutics: Global Markets
- An overview of the global market for melanoma therapeutics
- Analyses of global market trends, with data from 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Description of various treatment options such as chemotherapy, surgical resection, biochemotherapy, immunotherapy, photodynamic treatment, and targeted therapies; and various treatment approaches such as single-drug or combination regimens, tailored to the tumor's location, stage, and patient's overall health
- A look at the advancements in the genetic profiling of melanocytes and identification of novel molecules that involved in melanoma's development, and coverage of new potential therapeutic target discovery
- Information on innovation, technological advancements, and the launch of novel products from market players
- Detailed analysis of the regulatory framework and policies and product pipeline of the industry
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
- Comprehensive company profiles of the leading players of the industry
Over-the-Counter (OTC) Drugs and Dietary Supplements: Opportunities for Consumer Goods Distributors
- An overview of the global market for over-the-counter drugs and dietary supplements
- Estimation of the market size and analyses of global market trends with data from 2022, 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Highlights of the current and future market potential and quantification of the market by therapeutic classification, distribution channel, and geographic region
- Discussion on market opportunities for over-the-counter drugs and dietary supplement applications, industry structure, and regulatory scenarios
- Information on latest developments in the healthcare interoperability solutions and new industry research, upcoming technologies, and economic trends
- Identification of challenges and discussion on how to overcome from those to reach its commercialization potential, and ESG trends of the market
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
- Comprehensive company profiles of the leading players of the industry
Global Herbal Medicine Market
- An overview of the current and future global markets for herbal medicines
- Analyses of the global market trends, with historical market revenue data (sales figures) for 2021-2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Estimation of the actual market size and revenue forecast for global herbal medicine market in USD million values, and corresponding market share analysis based on the product type, dosage form, application area, distribution/sales channel, and region
- In-depth information (facts and figures) concerning the growth driving factors, opportunities and challenges, prospects, technologies, regulatory scenarios, and impact of macroeconomic variables on herbal medicines market
- Evaluation of scientific evidence supporting the efficacy and safety of herbal medicines for various health conditions
- Detailed description of ESG spcific developments with emphasis on importance of ESG, consumer attitudes, risks and opportunity assessment, and ESG followed practices
- A look at the major vendors in the global market for herbal medicines, and analyze the structure of the industry (e.g., company value share analysis, concentration, M&A deals, and venture fundings)
- Patent analysis covering significant allotments of recent patent grants across each major category
- Profile descriptions of the leading market players
Diagnostics and Therapeutics for HIV: Global Markets
- An overview of the global markets for diagnostics and therapeutics for the HIV disease
- Estimation of market size and analyses of global market trends, with data from 2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Characterization and quantification of market potential for therapeutic drugs for HIV virus by drug categories, diagnostic test types, application sectors and regions
- Evaluation of the market dynamics such as drivers, restraints, current industry trends and patterns and assessment of cost implications for treatments across a range of countries
- Insights into the regulatory scenario for United States, Europe, and Japan to provide an overview of the regulations for new drug launches and diagnostic kits, and coverage of ongoing research and future direction of the market
- Detailed description of the competitive landscape, product mapping, major player's strategic initiatives, R&D activities, and other initiatives
- Profiles of the key companies
Global Myasthenia Gravis Treatment Market: Forecast and Trends
- A comprehensive overview and up-to-date analysis of the global market for myasthenia gravis (MG) treatments
- Analyses of the global market trends, with historical market revenue data (sales figures) for 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Estimation of the actual market size, revenue forecast and potential growth share analysis for MG treatments based on product type, route of treatment, drug class, end user, and region
- In-depth information (facts and figures) concerning the major factors influencing the progress of this market (drivers, restraints, opportunities, and industry-specific challenges) with respect to specific growth trends, upcoming prospects, and contributions to the overall market
- Analysis of the market growth opportunities with a holistic review of Porter’s five forces analysis and PESTLE analysis considering both micro- and macro environmental factors prevailing in marketplace
- Understanding of the importance of ESG in the myasthenia gravis market, consumer attitudes, risks and opportunity assessment, and ESG followed practices by pharmaceutical and biotech companies
- Discussion of the key factors driving the growth of myasthenia gravis treatments market, industry trends, and new developments
- Patent analysis covering significant allotments of recent patent grants across each major category
- Identification of the top pharmaceutical and biotech companies that are considered as leaders in their field, as well as technological means these companies are using to exploit their markets and dominate the market in their fields
- Profile descriptions of the leading market players